Q3 2024 Sotera Health Co Earnings Call Transcript
Key Points
- Sotera Health Co (SHC) reported year-over-year top and bottom line growth with an 8.5% increase in total company revenues and a 9% increase in adjusted EBITDA.
- Nordion, a segment within the sterilization services business, delivered a 28% year-over-year revenue increase, driven by the timing of reactor harvest schedules.
- Nelson Labs, the lab testing and advisory services business, grew its top line by 7% and bottom line by 9% compared to the third quarter of 2023.
- The company maintains a strong liquidity position with over $700 million of available liquidity, including $307 million of unrestricted cash.
- Sotera Health Co (SHC) reaffirmed its full-year 2024 outlook ranges for revenue and adjusted EBITDA growth in the range of 4% to 6%.
- Sterigenics, the largest reporting segment, experienced a decline in segment income margins by approximately 70 basis points due to higher employee compensation costs.
- The company faced unfavorable changes in foreign currency exchange rates, impacting revenue growth across segments.
- Nelson Labs anticipates a mid-single-digit revenue decline in Q4 due to a decrease in expert advisory services revenue.
- The company's capital expenditures for 2024 are expected to be lower than initially planned, primarily due to timing delays in cobalt development projects and vendor performance issues.
- Sotera Health Co (SHC) continues to face challenges with the stringent NESHAP regulations, which could impact the industry overall.
Good morning and welcome to the Sotera Health third-quarter 2024 conference call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Vice President of Investor Relations and Treasurer, Jason Peterson. Jason, please go ahead.
Good morning and thank you. Welcome to Sotera Health's third-quarter 2024 earnings call. You can find today's press release and accompanying supplemental slides on the investor section of our website at soterahealth.com. This webcast is being recorded, and a replay will be available in the investor section of the Sotera Health website.
On the call with me today are Chairman and Chief Executive Officer, Michael Petras; and Chief Financial Officer, Jon Lyons. During the call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
